C. Abasq

1.2k total citations
29 papers, 358 citations indexed

About

C. Abasq is a scholar working on Dermatology, Immunology and Allergy and Pathology and Forensic Medicine. According to data from OpenAlex, C. Abasq has authored 29 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Dermatology, 6 papers in Immunology and Allergy and 5 papers in Pathology and Forensic Medicine. Recurrent topics in C. Abasq's work include Dermatology and Skin Diseases (7 papers), Autoimmune Bullous Skin Diseases (4 papers) and Vascular Malformations and Hemangiomas (4 papers). C. Abasq is often cited by papers focused on Dermatology and Skin Diseases (7 papers), Autoimmune Bullous Skin Diseases (4 papers) and Vascular Malformations and Hemangiomas (4 papers). C. Abasq collaborates with scholars based in France, Réunion and Italy. C. Abasq's co-authors include P. Joly, L. Misery, Hugo Mouquet, François Tron, E. Brenaut, Danièle Gilbert, V. Grassi, Philippe Musette, Steeve Genestet and Pascale Marcorelles and has published in prestigious journals such as Journal of the American Academy of Dermatology, Nature Reviews Neurology and British Journal of Dermatology.

In The Last Decade

C. Abasq

23 papers receiving 348 citations

Peers

C. Abasq

PFM

RHEUM

GENET

DERMA

PHYSI

Ragıp Ertaş Türkiye

Yun‐Ting Chang Taiwan

Wen-Shuo Wu United States

Mona A. Atwa Egypt

Thomas Gentinetta Switzerland

Mauro Cancian Italy

Danielle Peterson United States

Sheridan Lam United States

D. Timlin United Kingdom

Samantha Eisman Australia

Ragıp Ertaş Türkiye

C. Abasq

159 ×0.9

PFM

277 ×2.0

RHEUM

146 ×1.3

GENET

127 ×1.4

DERMA

49 ×1.2

PHYSI

Citations per year, relative to C. Abasq C. Abasq (= 1×) peers Ragıp Ertaş

Countries citing papers authored by C. Abasq

Since Specialization

Citations

This map shows the geographic impact of C. Abasq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Abasq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Abasq more than expected).

Fields of papers citing papers by C. Abasq

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Abasq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Abasq. The network helps show where C. Abasq may publish in the future.

Co-authorship network of co-authors of C. Abasq

This figure shows the co-authorship network connecting the top 25 collaborators of C. Abasq. A scholar is included among the top collaborators of C. Abasq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Abasq. C. Abasq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hillmann, Kathrin, Vasiliki Chasapi, Sergio Vañó‐Galván, et al.. (2025). Quality of life, psychosocial difficulties and bullying in paediatric patients with alopecia areata: a European cross-sectional study. British Journal of Dermatology. 193(6). 1165–1173. 1 indexed citations

Maruani, A., S. Barbarot, C. Abasq, et al.. (2023). Factors associated with early relapse of infantile haemangioma in children treated for at least six months with oral propranolol: A case-control study using the 2014–2021 French Ouest DataHub. Annales de Dermatologie et de Vénéréologie. 150(3). 189–194. 3 indexed citations

Tancrède‐Bohin, Emmanuelle, M. Alexandre, S. Oro, et al.. (2023). Efficacy and safety of anti-COVID-19 vaccination in patients with autoimmune blistering diseases: A French national study. Journal of the American Academy of Dermatology. 90(1). 204–208. 2 indexed citations

Mahé, E., J. Miquel, C. Abasq, et al.. (2022). Perialar intertrigo in children and adolescents: A multicenter prospective study of 41 cases. Pediatric Dermatology. 39(5). 702–707. 1 indexed citations

Tétart, F., B. Milpied, A. Maruani, et al.. (2021). Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Series of 49 French Pediatric Cases. The Journal of Allergy and Clinical Immunology In Practice. 10(1). 267–274.e5. 22 indexed citations

Fluhr, Joachim W., et al.. (2021). Teledermatology in Times of COVID-19 Confinement: Comparing Patients’ and Physicians’ Satisfaction by the Standardized Brest Teledermatology Questionnaire. Dermatology. 237(2). 191–196. 15 indexed citations

Boccara, O., Ludovic Martin, D. Bessis, et al.. (2021). Central nervous system screening in capillary malformation-arteriovenous malformation syndrome: An observational study. Journal of the American Academy of Dermatology. 87(4). 914–916. 4 indexed citations

Barbarot, S., F. Poizeau, E. Mahé, et al.. (2020). Drug survival and postdrug survival of systemic treatments in a national French cohort of children with atopic dermatitis. British Journal of Dermatology. 183(2). 376–378.

Boccara, O., J. Mazereeuw‐Hautier, Ludovic Martin, et al.. (2020). Malformations capillaires multiples : intérêt du dépistage systématique des malformations artérioveineuses du système nerveux central. Annales de Dermatologie et de Vénéréologie. 147(12). A101–A101.

10.

Phan, C., Alain Beauchet, J. Mazereeuw‐Hautier, et al.. (2019). Evaluation of Children with Psoriasis from the BiPe Cohort: Are Patients Using Biotherapies in Real Life Eligible for Phase III Clinical Studies?. Pediatric Drugs. 21(3). 169–175. 6 indexed citations

11.

Couloigner, Vincent, et al.. (2019). Hémihypertrophie faciale associée à une mutation dans le gène PIK3CA. Annales de Dermatologie et de Vénéréologie. 146(12). A249–A249. 1 indexed citations

12.

Dreyfus, I., C. Chiavérini, Christine Labrèze, et al.. (2018). Caractéristiques cliniques et évolutives de la kératodermie aquagénique de l’enfant : étude rétrospective de 12 cas. Annales de Dermatologie et de Vénéréologie. 145(4). 250–256. 2 indexed citations

13.

Chiavérini, C., Stéphanie Leclerc‐Mercier, E. Bourrat, et al.. (2017). Pain and quality of life evaluation in patients with localized epidermolysis bullosa simplex. Orphanet Journal of Rare Diseases. 12(1). 119–119. 36 indexed citations

14.

Huet, F., et al.. (2017). Syndrome d’hypersensibilité médicamenteuse et agranulocytose, une association rare. Archives de Pédiatrie. 24(8). 752–756. 4 indexed citations

15.

Gaultier, Frédérick, C. Prost‐Squarcioni, Philippe Bernard, et al.. (2016). Recommandations pour la prise en charge buccodentaire des patients atteints de maladies bulleuses auto-immunes avec atteinte buccale. Annales de Dermatologie et de Vénéréologie. 144(3). 182–190. 3 indexed citations

16.

Misery, L., E. Brenaut, Raphaële Le Garrec, et al.. (2014). Neuropathic pruritus. Nature Reviews Neurology. 10(7). 408–416. 90 indexed citations

17.

Picard, D, Jacques Bénichou, C. Abasq, et al.. (2014). Increased prevalence of psoriasis in patients with coronary artery disease: results from a case–control study. British Journal of Dermatology. 171(3). 580–587. 17 indexed citations

18.

Misery, L., Délphine Legoupil, M. Schöllhammer, et al.. (2014). Annonce d’une mauvaise nouvelle en dermatologie. Annales de Dermatologie et de Vénéréologie. 141(11). 729–735. 3 indexed citations

19.

Abasq, C. & L. Misery. (2012). Pityriasis versicolor et autres dermatoses liées à Malassezia sp. (à l’exclusion de la dermatite séborrhéique). 7(1). 1–5. 1 indexed citations

20.

Abasq, C., Hugo Mouquet, Danièle Gilbert, et al.. (2009). ELISA Testing of Anti–Desmoglein 1 and 3 Antibodies in the Management of Pemphigus. Archives of Dermatology. 145(5). 529–35. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact